Tuberculosis News and Research

Latest Tuberculosis News and Research

Malaria detection using breath analyzers

Researchers are on the verge of developing a new breath test that could detect malaria. The team from Washington University in St. Louis found that malaria in blood leaves a typical “breathprint” that is unique and can be detected using a breath analyzer test.

6 Nov 2017

Using biologics during pregnancy may not raise infant's risk for opportunistic infections

Using a biologic therapy to manage rheumatoid arthritis may not significantly increase an infant's risk for developing opportunistic infections like pneumonia, meningitis, and tuberculosis, according to new research findings presented this week at the 2017 ACR/ARHP Annual Meeting in San Diego.

6 Nov 2017

Scientists solve decade-old mystery that could lead to development of new treatments for TB

Scientists have solved a decade-old mystery that could eventually lead to the development of earlier treatments for one of the world's deadliest diseases, which affects up to 2 billion people.

1 Nov 2017

Neutron crystallography study could open avenues for new drugs to battle diseases

Scientists at the Department of Energy’s Oak Ridge National Laboratory have performed neutron structural analysis of a vitamin B6-dependent protein, potentially opening avenues for new antibiotics and drugs to battle diseases such as drug-resistant tuberculosis, malaria, and diabetes.

1 Nov 2017

GHIT Fund announces US$16.7 million to support development of new drugs, vaccines and diagnostics

The Global Health Innovative Technology Fund, a unique Japanese public-private partnership formed to battle infectious diseases around the globe, today announced US$16.7 million to support development of new compounds for fighting malaria and tuberculosis, a leishmaniasis vaccine and drug, and a treatment for a long-ignored flesh-eating infection.

31 Oct 2017

Study into killer T-cell activity could provide roadmap for tackling antibiotic resistance

In a study that could provide a roadmap for combatting the rising threat of drug-resistant pathogens, researchers have discovered the specific mechanism the body's T cells use to kill bacteria.

27 Oct 2017

ACS recognizes contributions of five surgeons with Surgical Humanitarian and Volunteerism Awards

Last night, five surgeons received the 2017 American College of Surgeons/Pfizer Surgical Humanitarian Awards and Surgical Volunteerism Awards in recognition of their selfless efforts as volunteer surgeons who provide care to medically underserved patients abroad.

23 Oct 2017

Rutgers researchers to explore ways for tackling emerging fungal infections

In recent years, hospitals nationwide have been reporting an increase in life-threatening illnesses resulting from a deadly fungal infection caused by the yeast Candida auris that can enter the bloodstream. This yeast is difficult to identify and often does not respond to commonly used antifungal drugs, leading to high mortality.

23 Oct 2017

Scientists develop novel antimicrobials to tackle multidrug-resistant bacteria

Scientists at the University of Surrey in collaboration with research partners at the University of Sheffield and University of Würzburg, Germany, have developed novel antimicrobials, which could be used to treat infections, caused by multidrug-resistant bacteria.

23 Oct 2017

New model predicts how E. coli bacteria respond to temperature changes, genetic mutations

Researchers at the University of California San Diego have developed a genome-scale model that can accurately predict how E. coli bacteria respond to temperature changes and genetic mutations.

13 Oct 2017

NTNU researchers reveal how HCV converts innocent cells into virus factories

The Hepatitis C (HCV) virus is a sly enemy to have in one's body. Not only does it manage to make itself invisible to the immune system by breaking down communication between the immune cells, it also builds secret virus "factories" that quickly go into mass production.

13 Oct 2017

Academy of Medical Sciences announces new UK-India scheme to address challenge of AMR

The Academy of Medical Sciences is today (Friday, 13th October) announcing the pledge from The Yusuf and Farida Hamied Foundation1 for a scheme to build stronger research links between the UK and India to jointly address the challenge of antimicrobial resistance (AMR).

12 Oct 2017

TB Alliance announces phase 1 clinical trials of two novel tuberculosis drugs

TBA-7371 and sutezolid entered phase 1 clinical trials, TB Alliance announced today. Both compounds have proceeded through early preclinical development and were granted "Investigative New Drug" status by the U.S. Food and Drug Administration. The phase 1 clinical trials are presently ongoing.

11 Oct 2017

Trial reveals value of tuberculosis chemoprophylaxis in HIV-infected people

Long-term follow-up in the ANRS TEMPRANO trial confirms that tuberculosis chemoprophylaxis in HIV-infected people is more than ever relevant in resource-limited countries.

10 Oct 2017

NIH awards $2.3 million grant to Umass Amherst microbiologist for TB research

The National Institutes of Health announced today that microbiologist Sloan Siegrist at the University of Massachusetts Amherst has received a five-year, $2.3 million National Institutes of Health New Innovator Award, which supports "unusually innovative research from early career investigators," to study the bacterium that causes tuberculosis (TB).

5 Oct 2017

Study finds no association between BCG vaccine and childhood asthma

Childhood asthma is a serious public health challenge in Québec and throughout the world. Although the immune mechanisms implicated in the development of childhood asthma are not fully understood, some studies seem to suggest that the BCG vaccine, used in tuberculosis prevention, may have a protective effect on childhood asthma.

3 Oct 2017

WHO report shows serious lack of new antibiotics to combat drug-resistant infections

A report, Antibacterial agents in clinical development - an analysis of the antibacterial clinical development pipeline, including tuberculosis, launched today by WHO shows a serious lack of new antibiotics under development to combat the growing threat of antimicrobial resistance.

20 Sep 2017

New antibiotic development slowing - warns World Health Organization

According to a new report from the World Health Organization (WHO) released yesterday, antibiotics development at present is not at par with the rising antimicrobial resistance worldwide and soon the demand may outgrow the supply. The WHO warns that this could mean that pathogens causing these infections could mean a great threat for humans in the coming years.

19 Sep 2017

'Pocket' project develops new low-cost test for accurate TB detection

Tuberculosis (TB) is a major global health issue. According to the World Health Organisation (WHO), every year there are worldwide 8.8 million new active TB cases and nearly 2 million TB deaths - 5000 every day - mostly in the poorest communities of the developing world.

19 Sep 2017

Global Burden of Disease study reveals latest findings on state of world’s health

Today, the Global Burden of Disease study publishes its latest global estimates for the state of the world’s health in The Lancet. The GBD is the only annual, comprehensive, peer-reviewed assessment of global trends in health, providing global and national estimates on more than 330 diseases, causes of death, and injuries in 195 countries and territories worldwide.

18 Sep 2017

Tuberculosis News and Research

Latest Tuberculosis News and Research

Malaria detection using breath analyzers

Using biologics during pregnancy may not raise infant's risk for opportunistic infections

Scientists solve decade-old mystery that could lead to development of new treatments for TB

Neutron crystallography study could open avenues for new drugs to battle diseases

GHIT Fund announces US$16.7 million to support development of new drugs, vaccines and diagnostics

Study into killer T-cell activity could provide roadmap for tackling antibiotic resistance

ACS recognizes contributions of five surgeons with Surgical Humanitarian and Volunteerism Awards

Rutgers researchers to explore ways for tackling emerging fungal infections

Scientists develop novel antimicrobials to tackle multidrug-resistant bacteria

New model predicts how E. coli bacteria respond to temperature changes, genetic mutations

NTNU researchers reveal how HCV converts innocent cells into virus factories

Academy of Medical Sciences announces new UK-India scheme to address challenge of AMR

TB Alliance announces phase 1 clinical trials of two novel tuberculosis drugs

Trial reveals value of tuberculosis chemoprophylaxis in HIV-infected people

NIH awards $2.3 million grant to Umass Amherst microbiologist for TB research

Study finds no association between BCG vaccine and childhood asthma

WHO report shows serious lack of new antibiotics to combat drug-resistant infections

New antibiotic development slowing - warns World Health Organization

'Pocket' project develops new low-cost test for accurate TB detection

Global Burden of Disease study reveals latest findings on state of world’s health

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Tuberculosis News and Research

Latest Tuberculosis News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in